Data for Progress and the Justice Collaborative Institute urge American authorities to open safe injection sites to prevent overdose deaths and the spread of infectious diseases.
The EMCDDA provides data on the implications of the pandemic for harm reduction and treatment providers, from managing staff shortages to using mobile or online platforms.
HRI and INPUD call on the international community to ensure the continuation of harm reduction services and prioritise community leadership to ensure people who use drugs are not left behind in the COVID-19 response.
Frontline AIDS and the Global Fund offer guidance to overcome the stigma, discrimination, violence, punitive laws and policies that prevent vulnerable populations from accessing HIV services.
UNODC provides evidence that the COVID-19 pandemic and lockdown restrictions are disrupting drug markets to varying degrees, from drug shortages to changes in mode of transport.
The Global Commission on Drug Policy advocates for more effective responses to transnational organised crime and drug trafficking through both targeted law enforcement approaches and development strategies.
WHO and UNODC offer guidelines for the international community to develop effective, evidence-based and ethical treatment services for drug use disorders.
IDPC and the Japan Advocacy Network for Drug Policy provide an overview of drug use in Japan, responses by public authorities and available support by civil society.
